Cooley M&A

JANUARY 23, 2024

Sponsor-led take-private transactions – and hostile takeovers – come to life sciences So-called take-private transactions led by a private equity sponsor have become a hot topic in healthcare. billion, while EQT acquired Dechra Pharma, a veterinary products business, in an all-cash acquisition for $6.1 billion.

Marketability 52

Marketability Equity Private Equity Firm Finance 52

Reynolds Holding

OCTOBER 10, 2023

17] This “modernization” effort might better be characterized as an insulation effort—insulating corporate managers from scrutiny. [18] The adopting release also addresses these topics, albeit more practically than did the proposing release. 27, 2023) (“Elliott 2”), [link]. Letter from Elliott 2 at n. 8] Release at 51. [9]

Marketability 49

Marketability Equity Technology Finance 49

Reynolds Holding

FEBRUARY 1, 2023

Strategic acquirors that have thoughtfully managed their balance sheets and private equity funds that have ample dry powder may be eager to pursue tech (and other) targets that would have previously been out of reach at the much higher valuations many companies enjoyed in 2021.

Finance 45

Finance Equity Technology Banking 45